Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correction to: Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
Gelsomino F, Tiseo M, Barbieri F, Riccardi F, Cavanna L, Frassoldati A, Delmonte A, Longo L, Dazzi C, Cinieri S, Colantonio I, Sperandi F, Lamberti G, Brocchi S, Tofani L, Boni L, Ardizzoni A. Gelsomino F, et al. Among authors: brocchi s. Br J Cancer. 2021 Jul;125(2):306. doi: 10.1038/s41416-021-01439-1. Br J Cancer. 2021. PMID: 34012035 Free PMC article. No abstract available.
Co-alteration of c-Met and ROS1 in Advanced NSCLC: ROS1 Wins.
Rihawi K, Cinausero M, Fiorentino M, Salvagni S, Brocchi S, Ardizzoni A. Rihawi K, et al. Among authors: brocchi s. J Thorac Oncol. 2018 Mar;13(3):e41-e43. doi: 10.1016/j.jtho.2017.10.024. J Thorac Oncol. 2018. PMID: 29472059 Free article. No abstract available.
Phase 2 study of NAB-paclitaxel in SensiTivE and refractory relapsed small cell lung cancer (SCLC) (NABSTER TRIAL).
Gelsomino F, Tiseo M, Barbieri F, Riccardi F, Cavanna L, Frassoldati A, Delmonte A, Longo L, Dazzi C, Cinieri S, Colantonio I, Sperandi F, Lamberti G, Brocchi S, Tofani L, Boni L, Ardizzoni A. Gelsomino F, et al. Among authors: brocchi s. Br J Cancer. 2020 Jul;123(1):26-32. doi: 10.1038/s41416-020-0845-3. Epub 2020 Apr 29. Br J Cancer. 2020. PMID: 32346071 Free PMC article. Clinical Trial.
New disappearance of complicated atheromatous plaques on rechallenge with PD-1/PD-L1 axis blockade in non-small cell lung cancer patient: follow up of an unexpected event.
Lamberti G, Gelsomino F, Brocchi S, Poerio A, Melotti B, Sperandi F, Gargiulo M, Borghi C, Fiorentino M, Ardizzoni A. Lamberti G, et al. Among authors: brocchi s. Ther Adv Med Oncol. 2020 Jul 24;12:1758835920913801. doi: 10.1177/1758835920913801. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32782484 Free PMC article.
Expected and non-expected immune-related adverse events detectable by CT.
Ciccarese F, Piccinino A, Brocchi S, Balacchi C, Dall'Olio FG, Massari F, Rihawi K, Paccapelo A, Ardizzoni A, Golfieri R. Ciccarese F, et al. Among authors: brocchi s. Eur J Radiol. 2021 May;138:109617. doi: 10.1016/j.ejrad.2021.109617. Epub 2021 Feb 25. Eur J Radiol. 2021. PMID: 33676358
PD-L1 Expression in Circulating Tumor Cells as a Promising Prognostic Biomarker in Advanced Non-small-cell Lung Cancer Treated with Immune Checkpoint Inhibitors.
Dall'Olio FG, Gelsomino F, Conci N, Marcolin L, De Giglio A, Grilli G, Sperandi F, Fontana F, Terracciano M, Fragomeno B, Tober N, Manferrari G, Brocchi S, Golfieri R, Fiorentino M, Ardizzoni A. Dall'Olio FG, et al. Among authors: brocchi s. Clin Lung Cancer. 2021 Sep;22(5):423-431. doi: 10.1016/j.cllc.2021.03.005. Epub 2021 Mar 16. Clin Lung Cancer. 2021. PMID: 33849808
45 results